[1] Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in china, 2019[J]. N Engl J Med, 2020.
[2] Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia[J]. N Engl J Med, 2020.
[3] 胡盛寿, 杨跃进, 朱曼璐, 等. 心脑血管基础疾病对严重急性呼吸综合征病情和发生多器官功能障碍综合征的影响[J]. 中华医学杂志, 2004, 84(15): 1257-1259.
[4] Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 2020,395(10 223):497-506.
[5] 国家卫生健康委.新型冠状病毒感染的肺炎诊疗方案(第五版),2020年2月4日.
[6] Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. In, Vol. 2020. https://www.who.int, 2020.
[7] Xintian X, Jingfang W, Jiannan F, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. SCIENCE CHINA Life Sciences, 2020.
[8] Hamming I, Timens W, Bulthuis M L, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis[J]. J Pathol, 2004, 203(2): 631-637.
[9] Oudit GY, Kassiri Z, Jiang C, et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS[J]. Eur J Clin Invest, 2009, 39(7): 618-625.
[10] 侯 涛. 武汉金银潭医师前线手记:为何体质强壮者会发展为重症. In, Vol. 2020. https://www.thepaper.cn: 澎湃新闻, 2020.
[11] Tamis-Holland J E, Jneid H, Reynolds H R, et al. Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the american heart association[J]. Circulation, 2019, 139(18): e891-e908.
[12] Nanshan Chen, Min Zhou, Xuan Dong, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study[J]. Lancet, 2020,395(10223):507-513.
[13] Vieillard B A, Caille V, Charron C, et al. Actual incidence of global left ventricular hypokinesia in adult septic shock[J]. Crit Care Med, 2008, 36(6): 1701-1706.
[14] Wang Z, Li H, Yao G, et al.Impacts of sepsis-induced myocardial dysfunction on hemodynamics, organ function and prognosis in patients with septic shock[J]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 2015, 27(3): 180-184.
[15] Zaky A, Deem S, Bendjelid K, et al. Characterization of cardiac dysfunction in sepsis: an ongoing challenge[J]. Shock, 2014, 41(1): 12-24.
[16] 中国医师协会急诊医师分会. 中国急诊感染性休克临床实践指南[J]. 中华急诊医学杂志, 2016, 25(3): 274-287.
[17] 江 华, 邓洪飞, 王 宇, 等. 洛匹那韦/利托那韦(LPV/r)用于2019新型冠状病毒肺炎的治疗可能性:基于既往冠状病毒肺炎研究的快速系统评价[J]. 中华急诊医学杂志, 2020, 2.
[18] 李太生, 曹 玮, 翁 利, 等. 北京协和医院关于“新型冠状病毒感染的肺炎”诊疗建议方案(V2.0)[J]. 协和医学杂志, 2020, 2: 5.
[19] Holshue M L, Debolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the united states[J]. N Engl J Med, 2020.